Last reviewed · How we verify
Infection caused by carbapenem-resistant acinetobacter baumannii-calcoaceticus complex
Approved treatments
- Unasyn · Pfizer
- Xacduro (Copackaged) · Entasis Therap
Xacduro works by binding to and inhibiting bacterial beta-lactamases, allowing antibiotics to effectively kill bacteria.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Infection caused by carbapenem-resistant acinetobacter baumannii-calcoaceticus complex patent landscape — cliff calendar, originator estates, attackable patents
- Infection caused by carbapenem-resistant acinetobacter baumannii-calcoaceticus complex treatment landscape brief
- Infection caused by carbapenem-resistant acinetobacter baumannii-calcoaceticus complex treatment updates RSS
Frequently asked questions about Infection caused by carbapenem-resistant acinetobacter baumannii-calcoaceticus complex
What drugs treat Infection caused by carbapenem-resistant acinetobacter baumannii-calcoaceticus complex?
Tracked treatments include Unasyn, Xacduro (Copackaged).
What is the treatment for Infection caused by carbapenem-resistant acinetobacter baumannii-calcoaceticus complex?
Standard treatment for Infection caused by carbapenem-resistant acinetobacter baumannii-calcoaceticus complex includes Unasyn, Xacduro (Copackaged). See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Infection caused by carbapenem-resistant acinetobacter baumannii-calcoaceticus complex patent cliff · Infection caused by carbapenem-resistant acinetobacter baumannii-calcoaceticus complex CI report
- Treatment: Unasyn · Pfizer
- Treatment: Xacduro (Copackaged) · Entasis Therap
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing